首页> 外文期刊>Journal of general internal medicine >Failure of evidence-based medicine in the treatment of hypertension in older patients.
【24h】

Failure of evidence-based medicine in the treatment of hypertension in older patients.

机译:循证医学在老年患者高血压治疗中的失败。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: Throughout the 1990s, the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure recommended initial antihypertensive therapy with a thiazide diuretic or a beta-blocker based on evidence from randomized, controlled trials, unless an indication existed for another drug class. The committee also recommended beta-blockers in hypertensive patients with a history of myocardial infarction (MI), and angiotensin-converting enzyme (ACE) inhibitors in patients with congestive heart failure (CHF). Our objective was to determine whether prescribing practices for older hypertensive patients are consistent with evidence-based guidelines. METHODS: We examined prescription patterns from January 1, 1991 through December 31, 1995 for 23,748 patients 65 years or older with a new diagnosis of hypertension from the New Jersey Medicaid program and that state's Pharmacy Assistance for the Aged and Disabled program (PAAD). We linked drug use data with information on demographic variables and comorbid medical conditions. RESULTS: During the study period, calcium channel blockers were the most commonly prescribed initial therapy for hypertension (41%), followed by ACE inhibitors (24%), thiazide diuretics (17%), and beta-blockers (10%). Eliminating patients with diabetes mellitus, CHF, angina, or history of MI did not substantially affect these results. Overall, initial use of a thiazide declined from 22% in 1991 to 10% in 1995, while initial use of a calcium channel blocker increased from 28% to 43%, despite publication during these years of studies demonstrating a benefit of thiazides in older patients. Only 15% of older hypertensive patients with a history of MI received beta-blockers. CONCLUSIONS: Prescribing practices for older hypertensive patients are not consistent with evidence-based guidelines. Interventions are needed to encourage evidence-driven prescribing practices for the treatment of hypertension.
机译:目的:在整个1990年代,全国高血压检测,评估和治疗联合委员会基于随机对照试验的证据,建议使用噻嗪类利尿剂或β-受体阻滞剂进行初始抗高血压治疗,除非存在另一种药物的适应症类。该委员会还建议对有心肌梗塞病史的高血压患者使用β受体阻滞剂,对充血性心力衰竭患者应使用血管紧张素转换酶抑制剂。我们的目的是确定老年高血压患者的处方做法是否与循证指南一致。方法:我们检查了从1991年1月1日至1995年12月31日的23748名65岁或65岁以上的患者的处方模式,这些患者通过新泽西州医疗补助计划和该州的老年人和残疾人药房计划(PAAD)获得了新的高血压诊断。我们将毒品使用数据与人口统计变量和共病医疗状况相关联。结果:在研究期间,钙通道阻滞剂是最常用的高血压初始治疗方法(41%),其次是ACE抑制剂(24%),噻嗪类利尿剂(17%)和β受体阻滞剂(10%)。消除患有糖尿病,CHF,心绞痛或MI史的患者基本上不会影响这些结果。总体而言,尽管这些年的研究表明噻嗪类药物对老年患者有益处,但噻嗪类药物的首次使用量从1991年的22%下降到1995年的10%,而钙通道阻滞剂的初始使用量从28%增加到43%。 。有心梗史的老年高血压患者中只有15%接受了β受体阻滞剂。结论:老年高血压患者的处方做法与循证指南不一致。需要采取干预措施来鼓励以证据为依据的处方治疗高血压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号